Mylan NV (NASDAQ:MYL) - Share price - Overview

Stock Report

Mylan NV MYL

Last Price
$40.96

Day Change
-0.64|-1.55%

As of 24/03/2017
16:00:00 EDT | USD
Minimum 15 Minutes Delay.

Last Close41.61
Day Range40.25 - 41.27
Mkt Cap21.93Bil
52-Wk Range33.60 - 50.40
Yield %-
ISINNL0011031208
Volume24,463,423
P/E44.52
P/S1.92
P/CF10.41

Share Price

Financials
201420152016
More ...
Income Statement
Revenue7,719.609,429.3011,076.90
Operating Income1,352.601,460.90701.60
Net Income929.40847.60480.00
Basic EPS2.491.800.94
Avg. Diluted Shares Outstanding398497521
Balance Sheet
Current Assets6,786.906,472.707,522.50
Non Current Assets9,099.7015,795.0027,203.70
Total Assets15,886.6022,267.7034,726.20
Current Liabilities5,305.704,122.205,040.70
Total Liabilities12,630.7012,503.3023,610.00
Total Equity3,255.909,764.4011,116.20
Cash Flow
Operating Cash Flow1,014.802,008.502,047.20
Capital Expenditure-754.40-871.70-750.60
Free Cash Flow260.401,136.801,296.60

In millions, except "Basic EPS". Currency is USD.

Company Profile

Mylan NV along with its subsidiaries is a pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Large-Value

Fiscal Year Ends

December

Employees

30,000
Key Stats
More ...
Price/Earning TTM44.26
Price/Book2.00
Price/Sales TTM2.08
Rev Growth (3 year avg)17.04
EPS Growth (3 year avg)-
Operating Margin % TTM6.33
Net Margin % TTM4.33
ROE TTM4.60
Debt/Equity1.37
Dividends
PreviousLatest
More ...
Declared Date15/03/0718/06/07
Ex-Div28/03/0727/06/07
Paid16/04/0716/07/07
Amnt0.060.06
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.